Position in RPRX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$601,440,910
+$45,627,247 QoQ
Shares Held
10,726,608
-7.4% QoQ
Ownership
1.86%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1
of 47 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swedbank AB holds $1,373,398,390 across 23 Biotechnology names. RPRX ranks #1 (43.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
10,726,608 | $601,440,910 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
968,092 | $233,281,129 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
282,444 | $140,298,407 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
189,848 | $118,377,821 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,314,787 | $75,232,112 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $45,801,140 | |
| 7 | INCY |
Incyte Corp
|
371,387 | $42,100,430 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
775,032 | $24,359,255 |
All Filings in RPRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $601,440,910 | 10,726,608 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $555,813,663 | 11,586,693 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $461,444,405 | 11,942,143 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $430,425,525 | 12,200,270 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $438,033,644 | 12,157,470 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $310,307,976 | 12,164,170 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $311,964,297 | 11,027,370 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $285,151,203 | 10,813,470 | Shares | Defined | 2024-07-11 | |
| 2023-12-31 | $153,621,401 | 5,468,900 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $107,254,566 | 3,951,900 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $118,352,074 | 3,850,100 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $110,069,668 | 3,054,945 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $72,693,759 | 1,839,417 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $55,887,045 | 1,390,917 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $20,747,454 | 493,517 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $19,227,422 | 493,517 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $19,666,652 | 493,517 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $17,835,704 | 493,517 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $13,424,225 | 327,500 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||